{
    "title": "103_hr1926",
    "content": "The Act titled \"National Narcotics Leadership Act Amendments of 1993\" implements the National Drug Control Strategy. The National Narcotics Leadership Act of 1988 is amended to allow the Director to require funding requests for specific initiatives consistent with the President's priorities for the National Drug Control Strategy. SEC. 3. REPORT ON REPROGRAMMING; OFFICE PERSONNEL RESTRICTION. The Director must report quarterly to Congress on any reprogramming of funds over $5,000,000 for National Drug Control Program activities. Additionally, a prohibition on political campaigning is imposed on Federal officers in the Office of National Drug Control Policy. Prohibition on political campaigning is imposed on Federal officers in the Office of National Drug Control Policy, preventing them from participating in Federal election campaign activities. Officers appointed by the President with Senate approval are allowed to make contributions to individual candidates. SEC. 4. NATIONAL DRUG CONTROL STRATEGY OUTCOME MEASURES. Section 1005(a) of the National Narcotics Leadership Act of 1988 is amended to include an evaluation of Federal drug control effectiveness in the National Drug Control Strategy, focusing on reduction of drug use and assessment of drug prevalence and frequency. The National Narcotics Leadership Act of 1988 is amended to include an evaluation of Federal drug control effectiveness in the National Drug Control Strategy, focusing on reduction of drug use and assessment of drug prevalence and frequency, including estimates from national, State, and local surveys of illicit drug use in various populations and settings. The curr_chunk discusses the assessment of drug availability in the United States, including quantities of cocaine, heroin, and marijuana, as well as the cultivation and destruction of poppy and coca. The curr_chunk provides data on hectares of poppy and coca cultivated and destroyed, metric tons of heroin and cocaine seized, cocaine processing labs destroyed, changes in price and purity of heroin and cocaine, controlled substances diverted from legitimate sources, and the effectiveness of Federal efforts. The curr_chunk focuses on assessing the reduction of consequences of drug use and availability, including the burdens drug users place on hospital emergency rooms in the United States. It also evaluates the effectiveness of Federal technology programs in improving drug detection capabilities at U.S. ports of entry. The curr_chunk discusses the impact of drug use on emergency rooms in the United States, including costs related to healthcare, crime, and the underground economy. The curr_chunk focuses on assessing drug treatment capacity in the United States, including public and private treatment availability, number of treatment slots, and data on intravenous drug users and pregnant women. The curr_chunk provides data on the availability of treatment for intravenous drug users and pregnant women, estimates the number of drug users who could benefit from treatment, and evaluates the success of drug treatment programs. The curr_chunk evaluates the success of drug treatment programs, including assessing the effectiveness of federal and state mechanisms for determining the quality of treatment programs, qualifications of personnel, and admission processes. The curr_chunk evaluates the quality of drug use measurement instruments and techniques for supply reduction and demand reduction activities. The curr_chunk assesses national drug use measurement instruments, techniques for measuring casual drug users and at-risk groups, actions to address deficiencies, factors limiting treatment availability, and proposed remedies. The curr_chunk discusses federal agencies cooperating with the Director to provide drug-related information for the National Drug Control Strategy reports to the President and Congress. The Director will report to the President and Congress on the assessment of drug use and availability in the United States, including the effectiveness of various programs in reducing drug use and availability. SEC. 5 amends Section 402(a)(7) of title 50, United States Code, to include the Director of the Office of National Drug Control Policy as a member of the National Security Council. SEC. 6 establishes the Counter-Drug Technology Assessment Center. The amendment to the National Narcotics Leadership Act of 1988 includes identifying and supporting the application of technology for drug treatment effectiveness. The National Narcotics Leadership Act of 1988 is amended to provide assistance and support to the Office of National Drug Control Policy through the Advanced Research Project Agency. Section 1008 is repealed and redesignated. The National Narcotics Leadership Act of 1988 is amended by repealing and redesignating section 1008, moving it to follow section 1007. SEC. 7 amends the National Narcotics Leadership Act to allow the Director to pay for necessary expenses for consultation on the National Drug Control Strategy. SEC. 8 authorizes appropriations as needed for fiscal year 1994. SEC. 9 amends the National Narcotics Leadership Act to terminate the Office of National Drug Control Policy on September 30, 1994."
}